Outreach

This video is private.

21 21

Dr. Bateman, BHC's Founder and Medical Director shares a personal message about the need for increasing medical provider education.

Move the Mark: Advance the Trajectory of ME/CFS & FM Care by donating today!

30 2

Rob Ence, BHC's Executive Director shares a personal message about the need for increasing medical provider education.

Move the Mark: Advance the Trajectory of ME/CFS & FM Care by donating today!

10 3

MEDICAL PROVIDER EDUCATION:

On August 25, 2020, Dr. Brayden Yellman addressed a group of adult and pediatric psychiatrist with the primary intention of supplementing their medical knowledge of ME/CFS as it relates to their specific medical practices.

The purpose of the lecture was to acknowledge that many who suffer from ME/CFS are often mistakenly diagnosed with primary psychiatric conditions, often in the complete absence of any recognition of an underlying severe multi-system illness.

The lecture reviews a case presentation of a patient whom, by official psychiatric diagnostic standards put forth by the DSM V, appears to have multiple primary psychiatric illnesses. 

The audience of providers is then challenged to question the utility and weaknesses of the existing diagnostic criteria for these psychiatric illnesses and is given a set of diagnostic tools to assist them in recognizing that the patient in this case presentation is actually suffering from prominent symptoms of ME/CFS.

19 5

MEDICAL PROVIDER EDUCATION:

Dr. Bateman presented at the University of Utah Health's "Project ECHO COVID-19" series. She addresses post-viral syndromes as it relates to chronic multisystem illness manifestations in COVID-19 long-haulers.

20 13

MEDICAL PROVIDER EDUCATION:
Dr. Brayden Yellman, rheumatologist at the Bateman Horne Center, discusses risk factors and commonly overlooked comorbidities within multi-system chronic illness presentations that can be useful for establishing diagnosis and targeting treatment interventions.

This presentation covers:

• Case presentations
• Small fiber neuropathy, mast cell activation, hypermobile EDS, dysautonomia, non-epileptic seizure, traumatic brain injury/cranio-cervical instability, and post infectious syndromes, headache syndromes.

9 4

MEDICAL PROVIDER EDUCATION:
In this presentation, Dr. Lucinda Bateman teaches about the effective use of evidence-based clinical diagnostic criteria to improve patient outcomes including:

1. Institute of Medicine/National Academy of Medicine (IOM/NAM) recommendations for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS):
• Impaired function, activity intolerance, post-exertional malaise, disordered and unrefreshing sleep, cognitive impairment, orthostatic intolerance
• Neurocognitive testing, cardiopulmonary exercise testing
• Focus on orthostatic intolerance syndromes and treatment strategies

2. Recognition of generalized pain amplification syndromes may reduce reliance on opioids and improve treatment outcomes:
• Decreasing and assessing triggers for amplified pain

3. Effective symptom management strategies

15 6

MEDICAL PROVIDER EDUCATION:

The Bateman Horne Center partnered with the University of Utah Health to conduct a three-part education series addressing clinical presentations of chronic pain and fatigue, and ways to assess and manage these conditions.

Part 1:
Dr. Lucinda Bateman, internist and Medical Director at the Bateman Horne Center, teaches about strategies and tools for systematically approaching complex chronic illness presentations.

This presentation contains the following:

• Case presentations
• Tools for measuring and tracking severity of pain and fatigue
• Tools for efficiently measuring and tracking impaired function

18 2

MEDICAL PROVIDER EDUCATION:

This video is geared toward medical professionals. However, we encourage everyone to watch it and share with loved ones to increase awareness of orthostatic intolerance in ME/CFS.

The National Academy of Medicine has reported there is sufficient evidence to suggest a high prevalence of orthostatic intolerance (OI) exists in those with ME/CFS.

OI is measurable, and the ability to identify and manage OI can greatly improve patient outcomes and daily functioning. Part 1 in this video series will address ways to assess and measure orthostatic intolerance, while Part 2 addresses interventions and management.

*Although this video focuses on the diagnostic criteria of OI in those with ME/CFS, the content within this video applies to all who may experience OI/POTS/neurally mediated hypotension.

These videos have been made possible by the Utah Medical Association and other generous donors.

94 6